Skip to main content
TipRanks
Go Ultimate75% OFF

Kestra Medical Technologies Ltd. (KMTS) Ratios

19 Followers

Kestra Medical Technologies Ltd. Ratios

KMTS's free cash flow for Q1 2027 was $-40.63M. For the 2027 fiscal year, KMTS's free cash flow was decreased by $-8.34M and operating cash flow was $-32.30M. See a summary of the company’s cash flow.

Financial ratios
RatiosApr 26Apr 25Apr 24Apr 23Apr 21
Liquidity Ratios
Current Ratio4.410.450.500.503.96
Quick Ratio4.280.350.440.443.96
Cash Ratio1.980.250.400.403.68
Solvency Ratio-1.24-0.32-0.51-0.51-1.17
Operating Cash Flow Ratio-1.62-2.19-1.90-1.90-4.52
Short-Term Operating Cash Flow Coverage-2635.580.00-3.41-3.410.00
Net Current Asset Value$ 123.55M$ -240.42M$ -137.81M$ -137.81M$ -2.56M
Leverage Ratios
Debt-to-Assets Ratio0.130.981.011.010.75
Debt-to-Equity Ratio0.18-0.22-0.33-0.3312.94
Debt-to-Capital Ratio0.15-0.28-0.50-0.500.93
Long-Term Debt-to-Capital Ratio0.14-0.25-0.17-0.170.92
Financial Leverage Ratio1.38-0.22-0.33-0.3317.28
Debt Service Coverage Ratio-18.11-12.25-2.83-2.83-27.84
Interest Coverage Ratio-17.85-13.65-14.29-14.29-28.00
Debt to Market Cap0.040.040.030.030.02
Interest Debt Per Share0.931.040.900.900.48
Net Debt to EBITDA0.39-0.48-0.33-0.330.05
Profitability Margins
Gross Profit Margin51.37%1.30%-139.59%-139.59%0.00%
EBIT Margin-153.10%-315.91%-1030.07%-1030.07%0.00%
EBITDA Margin-143.94%-274.34%-966.44%-966.44%0.00%
Operating Profit Margin-141.64%-305.83%-1054.01%-1054.01%0.00%
Pretax Profit Margin-138.04%-338.30%-1103.84%-1103.84%0.00%
Net Profit Margin-138.35%-338.39%-1104.04%-1104.04%0.00%
Continuous Operations Profit Margin-138.35%-338.39%-1104.04%-1104.04%0.00%
Net Income Per EBT100.22%100.03%100.02%100.02%100.55%
EBT Per EBIT97.46%110.62%104.73%104.73%103.69%
Return on Assets (ROA)-36.72%-204.84%-217.92%-217.92%-111.73%
Return on Equity (ROE)-50.69%44.95%71.64%71.64%-1930.97%
Return on Capital Employed (ROCE)-43.73%-655.44%-4195.15%-4195.15%-136.77%
Return on Invested Capital (ROIC)-43.73%-655.44%-338.91%-338.97%-130.96%
Return on Tangible Assets-36.72%-204.84%-217.92%-217.92%-111.73%
Earnings Yield-10.88%-8.70%-7.79%-7.79%-3.15%
Efficiency Ratios
Receivables Turnover6.5413.923.613.610.00
Payables Turnover1.691.152.972.970.00
Inventory Turnover6.908.348.658.650.00
Fixed Asset Turnover1.520.980.460.460.00
Asset Turnover0.270.610.200.200.00
Working Capital Turnover Ratio0.49-1.530.000.000.00
Cash Conversion Cycle-106.64-247.7020.2420.240.00
Days of Sales Outstanding55.8026.22101.08101.080.00
Days of Inventory Outstanding52.9143.7442.1942.190.00
Days of Payables Outstanding215.35317.67123.03123.030.00
Operating Cycle108.7169.96143.27143.270.00
Cash Flow Ratios
Operating Cash Flow Per Share-1.40-1.46-1.41-1.41-0.60
Free Cash Flow Per Share-2.00-1.71-1.72-1.72-0.61
Dividend Paid and CapEx Coverage Ratio-2.32-5.43-4.32-4.32-57.16
Capital Expenditure Coverage Ratio-2.34-5.77-4.50-4.50-88.97
Operating Cash Flow Coverage Ratio-1.75-1.60-1.78-1.78-1.31
Operating Cash Flow to Sales Ratio-0.86-2.60-9.13-9.130.00
Free Cash Flow Yield-9.64%-7.83%-7.87%-7.87%-2.79%
Valuation Ratios
Price-to-Earnings (P/E) Ratio-8.53-11.49-12.84-12.84-31.72
Price-to-Sales (P/S) Ratio12.7238.89141.78141.780.00
Price-to-Book (P/B) Ratio4.66-5.17-9.20-9.20612.58
Price-to-Free Cash Flow (P/FCF) Ratio-10.38-12.76-12.71-12.71-35.79
Price-to-Operating Cash Flow Ratio-14.81-14.98-15.53-15.53-36.19
Price-to-Earnings Growth (PEG) Ratio0.16-0.690.000.00-1.87
Enterprise Value Multiple-8.45-14.66-15.00-15.00-33.42
Enterprise Value1.16B1.12B1.11B1.11B1.08B
EV to EBITDA-8.45-14.66-15.00-15.00-33.42
EV to Sales12.1640.22144.97144.970.00
EV to Free Cash Flow-9.92-13.20-13.00-13.00-35.74
EV to Operating Cash Flow-14.16-15.49-15.88-15.88-36.14
Tangible Book Value Per Share4.45-4.23-2.37-2.370.04
Shareholders’ Equity Per Share4.45-4.23-2.37-2.370.04
Tax and Other Ratios
Effective Tax Rate-0.00-0.00-0.00-0.00-0.01
Revenue Per Share1.630.560.150.150.00
Net Income Per Share-2.25-1.90-1.70-1.70-0.69
Tax Burden1.001.001.001.001.01
Interest Burden0.901.071.071.071.04
Research & Development to Revenue0.200.562.072.070.00
SG&A to Revenue1.731.052.502.500.00
Stock-Based Compensation to Revenue0.350.050.160.160.00
Income Quality0.620.770.830.830.88

Currency in USD